Advertisement.
Advertisement.
Advertisement
Advertisement.
RGNX Regenxbio Inc
2,036
| Market Cap | $705.84M |
| Volume | 318,487.00 |
| 52-Wk High | $28.80 |
| 52-Wk Low | $10.49 |
REGENXBIO to Host Conference Call on August 1 to Discuss Second Quarter 2024 Financial Results and Recent Operational Highlights
PR Newswire•2 days ago
REGENXBIO to Host Conference Call on August 1 to Discuss Second Quarter 2024 Financial Results and Recent Operational Highlights REGENXBIO to Host Conference Call on August 1 to Discuss Second...
Share to Feed
REGENXBIO Announces Expansion of AFFINITY DUCHENNE Trial to Include a New Cohort of Younger Patients REGENXBIO Announces Expansion of AFFINITY DUCHENNE Trial to Include a New Cohort of Younger...
PR Newswire•1 month ago
REGENXBIO Announces Successful Pre-BLA Meeting with FDA to Support Accelerated Approval Pathway for RGX-121 for the Treatment of MPS II REGENXBIO Announces Successful Pre-BLA Meeting with FDA to...
PR Newswire•1 month ago
REGENXBIO Announces Leadership Transition REGENXBIO Announces Leadership Transition PR Newswire ROCKVILLE, Md., June 12, 2024 Curran Simpson, Chief Operating Officer, Appointed as President and...
PR Newswire•1 month ago
Goldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform.
Latest Ratings for RGNX
DateFirmActionFromTo Mar 2022SVB LeerinkMaintainsMarket Perform Feb 2022SVB...
Benzinga•2 months ago
REGENXBIO to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference REGENXBIO to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference PR Newswire ROCKVILLE...
PR Newswire•2 months ago
Latest Ratings for RGNX
DateFirmActionFromTo Mar 2022SVB LeerinkMaintainsMarket Perform Feb 2022SVB LeerinkMaintainsMarket Perform Jan 2022SVB LeerinkMaintainsMarket Perform
View More Analyst...
Benzinga•2 months ago
REGENXBIO to Participate in Upcoming Investor Conferences REGENXBIO to Participate in Upcoming Investor Conferences PR Newswire ROCKVILLE, Md., May 10, 2024 ROCKVILLE, Md., May 10, 2024 /PRNewswire...
PR Newswire•3 months ago
REGENXBIO Reports First Quarter 2024 Financial Results and Recent Operational Highlights REGENXBIO Reports First Quarter 2024 Financial Results and Recent Operational Highlights PR Newswire...
PR Newswire•3 months ago
REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024...
PR Newswire•3 months ago